Surveillance report
Evidence
Review and download supporting evidence. Includes the full guideline if available.
Supporting evidence
-
-
2022 exceptional surveillance of tuberculosis (NICE guideline NG33)
-
2018 surveillance (exceptional review) of tuberculosis (NICE guideline NG33)
-
Full guidance
-
Appendix A GDG and SDG Declarations of Interest (PDF 101 KB)
-
-
-
Appendix D EvTables RQ A, F, J, T, Y, EE, FF & GG (PDF 59 KB)
-
-
-
-
-
-
-
-
-
-
-
-
Appendix G1. CPH Review BCG vaccination uptake-effectiveness review (PDF 570 KB)
-
Appendix G2. CPH Review of reviews – other vaccination areas (PDF 1.03 MB)
-
Appendix G3. CPH Combined evidence statement document for G1 and G2 (PDF 189 KB)
-
Appendix G4. CPH review increasing the uptake of or adherence to treatment (PDF 665 KB)
-
Appendix G5. CPH Review Practice review on information education and support (PDF 228 KB)
-
Appendix G6. CPH review information education and support approaches (PDF 614 KB)
-
Appendix G7. Service Delivery cost impact report (PDF 537 KB)
-
-
Appendix G7. Service Delivery Expert Papers (EP 1to12) (PDF 917 KB)
-
Appendix G7. Service Delivery review appendices (PDF 765 KB)
-
-
-
-
-
-
-
Appendix H Warwick Evidence Diagnosis of LTBI report (PDF 5.53 MB)
-
Appendix H2 Warwick Evidence - addendum on sensitivity analyses (PDF 107 KB)
-
Appendix I Imperial College LTBI treatment report 30 April 2015 (PDF 1.26 MB)
-
Appendix I2 Imperial College LTBI treatment report addendum (PDF 139 KB)
-
-
Appendix K CG33 and CG117 referenced appendices (PDF 2.36 MB)
-
-
-
-
Appendix O CG33 & CG117 Deleted sections & appendices (PDF 1.77 MB)
-